Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Michelle A, Josephson"'
Autor:
Sharon M. Moe, Daniel C. Brennan, Mona D. Doshi, Robert S. Gaston, Susan B. Gurley, Muhammad A. Mujtaba, Rebecca J. Schmidt, Mark S. Segal, J. Kevin Tucker, Alexander C. Wiseman, Michelle A. Josephson
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN.
Autor:
Michelle A. Josephson, Alexander C. Wiseman, J. Kevin Tucker, Mark S. Segal, Rebecca J. Schmidt, Muhammad A. Mujtaba, Susan B. Gurley, Robert S. Gaston, Mona D. Doshi, Daniel C. Brennan, Sharon M. Moe
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN.
Autor:
Ling-Xin Chen, Michelle A. Josephson, Donald Hedeker, Kellie H. Campbell, Nicole Stankus, Milda R. Saunders
Publikováno v:
Kidney International Reports, Vol 2, Iss 4, Pp 645-653 (2017)
Dialysis patients aged ≥70 years derive improved life expectancy through kidney transplantation compared with their waitlisted counterparts, but guidelines are not clear about how to identify appropriate transplantation candidates. We developed a c
Externí odkaz:
https://doaj.org/article/0b26c5b8d13c4a369b17d6a2f2130382
Autor:
W. James Chon, Nidhi Aggarwal, Masha Kocherginsky, Brenna Kane, Jozefa Sutor, Michelle A. Josephson
Publikováno v:
Kidney Research and Clinical Practice, Vol 35, Iss 3, Pp 176-181 (2016)
Background: Although early monitoring of BK virus infection in renal transplant patients has led to improved outcomes over the past decade, it remains unclear whether monitoring for viremia is the best screening tool for BK virus nephropathy (BKVN).
Externí odkaz:
https://doaj.org/article/bfd29cc611b441e9835b1b608a587a78
Publikováno v:
Clin J Am Soc Nephrol
Despite the reduction in the incidence of acute rejection, a major risk factor for graft loss, there has been only modest improvement in long-term graft survival. Most cases of kidney graft loss have an identifiable cause that is not idiopathic fibro
Autor:
Vineeta Kumar, Kerry A. Leigh, Alan S. Kliger, Glenda Roberts, Sumit Mohan, Nicolae Leca, Deidre L. Sawinski, Michelle A. Josephson, Roslyn B. Mannon, Krista L. Lentine
Publikováno v:
Clinical Journal of the American Society of Nephrology.
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update
Autor:
Rolf N. Barth, Mark A. Hardy, Dixon B. Kaufman, Raghavendra G. Mirmira, Piotr Witkowski, David A. Baidal, Raja Kandaswamy, Louis H. Philipson, Chirag S. Desai, Melena D. Bellin, Piotr J. Bachul, Jason L. Gaglia, John J. Fung, Michelle A. Josephson, Oyedolamu K. Olaitan, Jonathan A. Fridell, John B. Buse, Peter G. Stock, Jason R. Wellen, Peter L. Abrams, Robert C. Harland, Bashoo Naziruddin, Jordan Pyda, Amittha Wickrema, Camillo Ricordi, Marwan S Abouljoud, Lloyd E. Ratner, Silke V. Niederhaus, Tomasz Kozlowski, Michael Charlton, Kumar Jayant, David C. Mulligan, R. Paul Robertson, James F. Markmann, Rachael C. Forbes, Robert J. Stratta, J. Michael Millis, Anthony J. Japour, Jon S. Odorico, Marlon F. Levy, Rodolfo Alejandro, Fouad Kandeel, Appakalai N. Balamurugan, Kenneth A. Andreoni, Yolanda T. Becker
Publikováno v:
Am J Transplant
Islet allotransplantation in the United States (US) is facing an imminent demise. Despite nearly three decades of progress in the field, an archaic regulatory framework has stymied US clinical practice. Current regulations do not reflect the state-of
Autor:
Vineeta Kumar, Mark A. Schnitzler, Tarek Alhamad, David A. Axelrod, Matthew Cooper, Dilek Ince, Yasar Caliskan, Asif Sharfuddin, Michelle A. Josephson, Alexis Guenette, Roslyn B. Mannon, Sruthi Ainapurapu, Krista L. Lentine, Meera N. Harhay
Publikováno v:
Clinical Transplantation. 35
The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges for solid organ transplant programs. While transplant activity has largely recovered, appropriate management of deceased donor candidates who are asymptomatic but h
Autor:
Meghan E, Kapp, Agnes B, Fogo, Candice, Roufouse, Behzad, Najafian, Jai, Radhakrishnan, Sumit, Mohan, Sara E, Miller, Vivette D, D'Agati, Jeffrey, Silberzweig, Tarek, Barbar, Tulasi, Gopalan, Vesh, Srivatana, Michele H, Mokrzycki, Judith A, Benstein, Yue-Harn, Ng, Krista L, Lentine, Vikram, Aggarwal, Jeffrey, Perl, Page, Salenger, Jay L, Koyner, Michelle A, Josephson, Michael, Heung, Juan Carlos, Velez, Alp, Ikizler, Anitha, Vijayan, Preethi, William, Bijin, Thajudeen, Marvin J, Slepian
Publikováno v:
Asaio Journal
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in coronavirus disease 2019 (COVID-19), a significant subset of patients experiences acute kidney inju
Publikováno v:
American Journal of Nephrology. 50:370-374
Background: Within-patient tacrolimus level variability >30% has been shown to be a risk factor for de novo donor-specific antibody formation and death-censored graft failure among kidney transplant recipients. The burden of tacrolimus variability an